Li‐Wen Hsu
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 4
- Drug Solubulity and Delivery Systems 2
- Biomaterials top 5%
- Genetics top 5%
- Mesenchymal stem cell research 3
- Molecular Medicine top 5%
- Transplantation top 10%
-
- Immunotherapy and Immune Responses 4
-
- Tissue Engineering and Regenerative Medicine 2
-
- Mitochondrial Function and Pathology 2
-
- Neonatal Health and Biochemistry 2
-
- Metabolism and Genetic Disorders 2
In The Last Decade
Li‐Wen Hsu
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 111
- Pharmaceutical Science 381
- Biomaterials 274
- Genetics 178
- Molecular Medicine 81
- Transplantation 30
Countries citing papers authored by Li‐Wen Hsu
This map shows the geographic impact of Li‐Wen Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Wen Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Wen Hsu more than expected).
Fields of papers citing papers by Li‐Wen Hsu
This network shows the impact of papers produced by Li‐Wen Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Wen Hsu. The network helps show where Li‐Wen Hsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li‐Wen Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2021 | 32 | |
| 3 | 2020 | 16 | |
| 4 | 2020 | 15 | |
| 5 | 2020 | 9 | |
| 6 | 2014 | 2 | |
| 7 | 2012 | 1 | |
| 8 | 2012 | 362 | |
| 9 | 2012 | 81 | |
| 10 | 2012 | 75 | |
| 11 | 2012 | 178 | |
| 12 | 2011 | 15 | |
| 13 | 2010 | 41 | |
| 14 | 2008 | 25 | |
| 15 | 2008 | 21 | |
| 16 | 2007 | 19 | |
| 17 | 2006 | 13 | |
| 18 | 2005 | 17 | |
| 19 | 2003 | 6 | |
| 20 | 2002 | 4 |
About Li‐Wen Hsu
Li‐Wen Hsu is a scholar working on Pharmaceutical Science, Biological Psychiatry and Genetics, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Advanced Drug Delivery Systems (4 papers), Mesenchymal stem cell research (3 papers), Tissue Engineering and Regenerative Medicine (2 papers), Mitochondrial Function and Pathology (2 papers), Drug Solubulity and Delivery Systems (2 papers), Neonatal Health and Biochemistry (2 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Pharmaceutical Science (381 citations), Biomaterials (274 citations) and Genetics (178 citations). Li‐Wen Hsu has collaborated with scholars based in Taiwan, Japan and Australia. Frequent co-authors include Hsing‐Wen Sung, Zi‐Xian Liao, Kiran Sonaje, Fwu‐Long Mi, Er‐Yuan Chuang, Mei‐Chin Chen, Shiaw-Min Hwang, Chiung-Tong Chen, Jyuhn-Huarng Juang and Yi‐Cheng Ho.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.